Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q3

8129.TEDINET S100Q4UF
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥1.06T2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥1.27T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥950.2bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥8.6bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥5.5bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥13.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥18.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥9.9bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥14.4bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥10.4bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥9.5bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.9bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥9.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥6.9bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥794.4bnat 2022-12-31Cons.Assets
Total assets¥702.4bnat 2022-03-31Cons.Assets
Total assets¥731.5bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥554.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥461.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥240.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥241.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥238.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥112.9bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥94.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥136.092022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.92022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥189.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥97.982021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥51.582021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥125.12022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥174.482021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥90.072021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio30.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.1bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.7bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-12-31¥7.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.6bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.8bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-12-31¥715m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-12-31¥1.02T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-12-31¥983.6bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥36.4bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥4.9bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥449m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥1.10T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥1.06T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥43.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥9.7bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥43.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥43.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.4bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2021-04-01 → 2021-12-31¥68.9bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2021-04-01 → 2021-12-31¥68.9bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥5m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.3bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2021-04-01 → 2021-12-31¥6.7bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2021-04-01 → 2021-12-31¥1.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥5.3bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2021-04-01 → 2021-12-31¥691m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2021-04-01 → 2021-12-31¥913.8bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2021-04-01 → 2021-12-31¥876.8bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥37.0bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2021-04-01 → 2021-12-31¥3.6bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥4.2bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥3.1bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥308m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥993.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥950.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥43.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥6.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 418
ItemContextValueUnit
Other noiPrior1YTDDuration1157000000JPY
Other noiCurrentYTDDuration1564000000JPY
Non operating incomePrior1YTDDuration4717000000JPY
Non operating incomeCurrentYTDDuration5234000000JPY
Interest expenses noePrior1YTDDuration56000000JPY
Interest expenses noeCurrentYTDDuration54000000JPY
Rent expenses on real estates noePrior1YTDDuration149000000JPY
Rent expenses on real estates noeCurrentYTDDuration160000000JPY
Other noePrior1YTDDuration174000000JPY
Other noeCurrentYTDDuration144000000JPY
Non operating expensesPrior1YTDDuration380000000JPY
Non operating expensesCurrentYTDDuration358000000JPY
Ordinary incomePrior1YTDDuration9887000000JPY
Ordinary incomeCurrentYTDDuration13428000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration71000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration115000000JPY
Gain on sales of investment securities eiPrior1YTDDuration1039000000JPY
Gain on sales of investment securities eiCurrentYTDDuration2784000000JPY
Other eiPrior1YTDDuration23000000JPY
Other eiCurrentYTDDuration19000000JPY
Extraordinary incomePrior1YTDDuration1134000000JPY
Extraordinary incomeCurrentYTDDuration2920000000JPY
Loss on disposal of noncurrent assets elPrior1YTDDuration105000000JPY
Loss on disposal of noncurrent assets elCurrentYTDDuration113000000JPY
Impairment loss elPrior1YTDDuration127000000JPY
Impairment loss elCurrentYTDDuration26000000JPY
Provision for loss on anti monopoly act elPrior1YTDDuration－JPY
Provision for loss on anti monopoly act elCurrentYTDDuration1400000000JPY
Other elPrior1YTDDuration394000000JPY
Other elCurrentYTDDuration359000000JPY
Extraordinary lossPrior1YTDDuration627000000JPY
Extraordinary lossCurrentYTDDuration1900000000JPY
Income before income taxesPrior1YTDDuration10394000000JPY
Income before income taxesCurrentYTDDuration14448000000JPY
Income taxes currentPrior1YTDDuration3080000000JPY
Income taxes currentCurrentYTDDuration4737000000JPY
Income taxes deferredPrior1YTDDuration377000000JPY
Income taxes deferredCurrentYTDDuration159000000JPY
Income taxesPrior1YTDDuration3457000000JPY
Income taxesCurrentYTDDuration4897000000JPY
Profit lossPrior1YTDDuration6936000000JPY
Profit lossCurrentYTDDuration9551000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration26000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration17000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration6910000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration9534000000JPY
Profit lossPrior1YTDDuration6936000000JPY
Profit lossCurrentYTDDuration9551000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-4105000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-692000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass